1 / 29

Regional Anaesthesia and Thromboprophylaxis

Regional Anaesthesia and Thromboprophylaxis. Dr Kate Fogg Royal Brompton Hospital. Regional Anaesthesia Epidural/spinal Risks/benefits Thromboprophylaxis s/c heparin (unfractionated/LMWH) anti-Xa or direct thrombin inhibitors antiplatelet agents warfarin

symona
Download Presentation

Regional Anaesthesia and Thromboprophylaxis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Regional Anaesthesia and Thromboprophylaxis Dr Kate Fogg Royal Brompton Hospital

  2. Regional Anaesthesia Epidural/spinal Risks/benefits • Thromboprophylaxis s/c heparin (unfractionated/LMWH) anti-Xa or direct thrombin inhibitors antiplatelet agents warfarin systemic heparinisation Can you put the two together or should you stop one in order to perform the other?

  3. Regional blocks • Drug administered directly to the spinal cord to locally block afferent and efferent nerve input. • Usually for major thoracic, abdominal and lower limb surgery • Local anaesthetic +/- opiates

  4. Spinal • Dural puncture • Single shot usually • 24-26G needle, pencil point • Less traumatic • Catheter rarely

  5. Epidural • Larger needle – 16 G • Loss of resistance technique • Epidural vessels • Usually a catheter technique • Trauma may be on insertion or removal of catheter

  6. Benefits • Improved analgesia, greater mobility, fewer opiate side-effects • Decrease stress response adverse cardiac, pulmonary and immune outcomes hypercoagulable state • Decrease troponin release in cardiac patients • ? Does this translate into clinical benefit

  7. Most impressive in high-risk patients undergoing major surgery • Decrease blood loss and transfusion requirement • Decrease thromboembolic complications • Decrease pneumonia and resp depression • Decrease MI and ARF • Decrease mortality

  8. Risks • Failure • Dural Tap • Catheter migration subdurally • Nerve damage • Epidural abscess • Epidural Haematoma

  9. Haematoma • Rare but potentially catastrophic • Tryba (1993) – 1:150,000 epidural anaesthetics, 1:220,000 spinals (review 1.5 million patients) Risk probably higher if on drugs altering coagulation • Vandermeulen (1994) review for case reports of haematoma • 75% associated with epidural, 25% spinal • 87% coagulation abnormalities/technical difficulties • Coag abnormalities include alcohol abuse, CRF, thrombocytopaenia as well as drugs

  10. Symptoms • Sharp back pain • New motor/sensory loss • Urinary retention • Variable and may be confused with effect of LA • Paraplegia • Need surgery within 8 hrs to get good or partial recovery.

  11. Putting the two together? • 1993 LMWH in USA b.d unlike in Europe o.d –sudden increase in reports of haematoma. • American Society of Regional anaesthesia and Pain Medicine – Consensus Statement ,2002 • German Society of Anaesthesia and Intensive Care Medicine 2004

  12. Unfractionated heparin • Vascular or cardiac cases • Avoid if other coagulopathy • Heparin delayed for 1hour after needle placement • Catheter removal 2-4 hr after last heparin • Post-op monitoring for at least 48 hrs

  13. Cardiac • Does the benefit outweigh the risk? • Can show less troponin release • Consistent decrease in ventilator time • Better analgesia on day 1 • ?fewer pulmonary complications • No consistent improvement in arrythmia/cardiac/renal/neurologic outcome • No effect on mortality

  14. Recent case reports of haematomas • Can achieve other benefits with beta blockers/multimodal analgesic techniques • ?only in high risk COPD patients or those elderly at high risk of confusion

  15. LMWH • Dose dependent antithrombotic effect by anti-Xa inhibition • Anti-Xa level not predictive of bleeding • Beware antiplatelet or oral anticoagulant • Needle placement 10-12 hours after last dose LMWH • Higher dose….wait 24hrs

  16. Post-op: • Catheter technique safe • B.D dosing; remove catheter beforehand. Wait 2hrs after catheter removal before first dose • O.D. can have indwelling catheter. Remove minimum of 10-12 hours after last dose. Subsequent dose minimum 2hrs later

  17. Oral anticoagulants • Stop 4-5 days before • PT/INR within normal limits • If on low dose post-op need to monitor INR daily • Catheter removal when INR<1.5

  18. Antiplatelet medications • Include: aspirin, NSAIDs, thienopyridine derivatives (ticlodipine/clopidogrel), GP IIb/IIIa antagonists (abciximab/tirofiban) • GPIIb/IIIa in acute coronary syndrome….unlikely to be heading for surgery where epidural needed • No wholly accepted test to guide antiplatelet therapy • CLASP study in obstetric patients – aspirin alone does not increase risk • NSAID alone no increased risk

  19. Actual risk of haematoma with clopidogrel etc unknown. • Based on half-lives etc… • Stop ticlodipine 14 days, clopidogrel 7 days • GPIIb/IIIa contraindicated with 4 weeks • Beware concurrent medications

  20. Little evidence increased surgical bleeding in non-cardiac studies • ? Stop only to make epidural safer (continue aspirin) • Usually on aspirin + clopidogrel because of intracoronary stent

  21. Drug eluting stents • Stop intimal hyperplasia which leads to early occlusion • Delay epithelialisation – hence need long term antiplatelet Rx • Stopping antiplatelet Rx before surgery may increase risk of infarct (combine hypercoagulable state+ poorly endothelialised stent) • Weigh benefit of epidural (and lesssurgical bleeding) v ischaemia/infarct • ? Combine the two ? After platelet function

  22. ? Plateletfunction monitoring • Spectrum of response to Rx • Can we identify which patients are higher risk? • Bleeding time • Optical light transmission aggregometry • Platelet function analyser • Modified TEG (Agarwal; Anaesthesiology 2006)

  23. Anti Xa fondaparinux • Synthetic pentasaccharide, pure anti Xa • 15hr half life • Less venous thromboembolic events than with LMWH in orthopaedic patients • Increased bleeding • Administered post-op (6hrs) • No studies with indwelling epidural catheters • Haematoma risk unclear

  24. Thrombin inhibitors • Recombinant hirudin dreivatives. • Inhibit free and clot bound thrombin • Argatobatran (L arginine derivative) similar action • No case reports spinal haematoma • Reports of spontaneous intracerebral bleed • No risk assessment statement given!

  25. For each individual patient a clear drug history is needed, an assessment of medical and surgical risk for their procedure, and an assessment of the additional benefit of a regional anaesthetic technique versus the risk of an epidural haematoma. In every patient undergoing a regional technique, rigorous post-op neurological monitoring is essential.

  26. Questions?

More Related